Search research articles
Contact Us
Filters
Showing results (11-20 of 70) with videos related to
Page
of 7
Sort By:
Annals of Operations Research
|
February 28, 2022
Optimal multi-stage group partition for efficient coronavirus screening
Yuvraj Gajpal, S S Appadoo, Victor Shi, et al.
International Journal of Environmental Research and Public Health
|
January 21, 2023
Public Health Risk Evaluation through Mathematical Optimization in the Process of PPPs
Mohammad Heydari, Kin Keung Lai, Victor Shi, et al.
International Journal of Environmental Research and Public Health
|
July 9, 2022
A Resilience Analysis of a Medical Mask Supply Chain during the COVID-19 Pandemic: A Simulation Modeling Approach
Yi Zheng, Li Liu, Victor Shi, et al.
Annals of Operations Research
|
October 12, 2020
Early box office prediction in China's film market based on a stacking fusion model
Yi Liao, Yuxuan Peng, Songlin Shi, et al.
Handbook of Experimental Pharmacology
|
December 23, 2016
Sacubitril/Valsartan (LCZ696) in Heart Failure
Yasser Khder, Victor Shi, John J V McMurray, et al.
International Journal of Cardiology
|
May 20, 2018
Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study
Victor Shi, Michele Senni, Hendrik Streefkerk, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
October 7, 2011
The efficacy and safety of valsartan in obese and non-obese pediatric hypertensive patients
Kevin E C Meyers, Kenneth Lieberman, Susan Solar-Yohay, et al.
Journal of Clinical Pharmacology
|
January 31, 2009
Pharmacokinetics of valsartan in pediatric and adolescent subjects with hypertension
Jeffrey Blumer, Donald L Batisky, Thomas Wells, et al.
Blood Pressure. Supplement
|
June 15, 2007
The effects of high-dose amlodipine/benazepril combination therapies on blood pressure reduction in patients not adequately controlled with amlodipine monotherapy
Steven G Chrysant, Daniel H Sugimoto, Marty Lefkowitz, et al.
Journal of the Cardiometabolic Syndrome
|
December 2, 2008
The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial
George Bakris, Allen Hester, Michael Weber, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 70) with videos related to
Sort By:
Page
of 7
Annals of Operations Research
|
February 28, 2022
Optimal multi-stage group partition for efficient coronavirus screening
Yuvraj Gajpal, S S Appadoo, Victor Shi, et al.
International Journal of Environmental Research and Public Health
|
January 21, 2023
Public Health Risk Evaluation through Mathematical Optimization in the Process of PPPs
Mohammad Heydari, Kin Keung Lai, Victor Shi, et al.
International Journal of Environmental Research and Public Health
|
July 9, 2022
A Resilience Analysis of a Medical Mask Supply Chain during the COVID-19 Pandemic: A Simulation Modeling Approach
Yi Zheng, Li Liu, Victor Shi, et al.
Annals of Operations Research
|
October 12, 2020
Early box office prediction in China's film market based on a stacking fusion model
Yi Liao, Yuxuan Peng, Songlin Shi, et al.
Handbook of Experimental Pharmacology
|
December 23, 2016
Sacubitril/Valsartan (LCZ696) in Heart Failure
Yasser Khder, Victor Shi, John J V McMurray, et al.
International Journal of Cardiology
|
May 20, 2018
Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study
Victor Shi, Michele Senni, Hendrik Streefkerk, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
October 7, 2011
The efficacy and safety of valsartan in obese and non-obese pediatric hypertensive patients
Kevin E C Meyers, Kenneth Lieberman, Susan Solar-Yohay, et al.
Journal of Clinical Pharmacology
|
January 31, 2009
Pharmacokinetics of valsartan in pediatric and adolescent subjects with hypertension
Jeffrey Blumer, Donald L Batisky, Thomas Wells, et al.
Blood Pressure. Supplement
|
June 15, 2007
The effects of high-dose amlodipine/benazepril combination therapies on blood pressure reduction in patients not adequately controlled with amlodipine monotherapy
Steven G Chrysant, Daniel H Sugimoto, Marty Lefkowitz, et al.
Journal of the Cardiometabolic Syndrome
|
December 2, 2008
The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial
George Bakris, Allen Hester, Michael Weber, et al.
Page
of 7